Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > HopSkipJump from culater, a BlowPast
View:
Post by ISAloser247 on Sep 09, 2011 6:42pm

HopSkipJump from culater, a BlowPast

posting from 10/21/2010, by culater:"If nothing else, ISA has taught me to be cautious. This appears to be a VERY GOOD stock to watch and pick up in the $1.00 range and wait for news, then sell. Like I should have done many more times with ISA than I did." funny how, 'psoriasis news story' shows up, ISA up 12%, unfortunately not up to $1.00 range! FIY: if anyone is looking for diamonds in a Snowfield (SNO) with Antonanus, the stock has been halted, something about not filing any financial statements in April, 2011--the familiar "unresolved issues", excuse.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities